Inicio › Colitis ulcerativa › Tennessee
Ensayos clínicos de Colitis ulcerativa en Tennessee
12 estudios sobre Colitis ulcerativa buscan participantes en Tennessee.
Ciudades en Tennessee
Texto oficial del estudio (inglés)
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
- Site US-003, Cordova
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 29 sept 2026 · NCT07845487Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Gastrointestinal Associates - Knoxville - Dowell Springs Boulevard /ID# 283861, Knoxville
- Gastro One - Memphis /ID# 283948, Memphis
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 29 sept 2026 · NCT07697456A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Site 017, Kingsport
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 29 sept 2026 · NCT07012395Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
- Xencor Investigative Site, Cordova
ReclutandoFase 1/2Se aceptan voluntarios sanos
Edades de 18 a 75 · Todos los sexos · Actualizado el 29 sept 2026 · NCT06619990Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Gastroenterology Center Of The Midsouth, Cordova
ReclutandoFase 3
Edades de 18 a 70 · Todos los sexos · Actualizado el 24 sept 2026 · NCT06937086LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- Skyline Gastroenterology of West Tennessee, Jackson
ReclutandoFase 2
Edades de 18 a 80 · Todos los sexos · Actualizado el 22 sept 2026 · NCT07415044LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
- Gastro One - Walnut Run Road, Cordova
ReclutandoFase 2
Edades de 18 a 80 · Todos los sexos · Actualizado el 22 sept 2026 · NCT07186101A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Tri-Cities Gastroenterology, Kingsport
ReclutandoFase 4
Edades de 18 a 80 · Todos los sexos · Actualizado el 15 sept 2026 · NCT06581328A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
- Gastro One, Cordova
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 ago 2026 · NCT07577856Study to Evaluate the Efficacy and Safety of Ponesimod (VSP-128) in Patients With Moderately to Severely Active Ulcerative Colitis
- Vanda Investigational Site, Nashville
ReclutandoFase 3
Edades de 18 a 75 · Todos los sexos · Actualizado el 18 ago 2026 · NCT07686081A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Cordova
ReclutandoFase 2
Edades de 18 a 80 · Todos los sexos · Actualizado el 12 mar 2026 · NCT07113522Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention
- Vanderbilt University, Nashville
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 8 may 2025 · NCT06750731De ClinicalTrials.gov, datos obtenidos el 30 sept 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.